Karin Schölin Bywall

Karin Schölin Bywall

Karin Schölin Bywall

Postdoc researcher

Karin Schölin Bywall is a postdoc researcher at CRB. She explores patients' preferences and perspectives on individualized treatment using prediction algorithms and digital health applications. The research is part of the NordForsk funded Personalized Medicine in RA by combining genomics, biomarkers, clinical and patient-derived data from the Nordic countries (NORA) project that will develop ways to tailor treatment for individual patients and to integrate patients' own benefit-risk tradeoffs in individualized treatment using digital tools. Karin Schölin Bywall is working with both qualitative exploration and quantitative preference elicitation methods, to explore how people balance their interests and values. She is also part of the IMI-funded PREFER project aiming to investigate methodologies to elicit informed patient preferences regarding the benefits and risks of drugs, from development through the entire cycle, to inform the decision-making process by regulators and HTA bodies.

Email: karin.bywall@crb.uu.se
Phone: +46 18 471 62 49


Methodology, rheumatoid arthritis and patient involvement

Drugs should benefit patients. By extension, they should have a say in designing research meant to find out what they think about drugs. Here, Karin Schölin Bywall shares her thoughts about involving patients in research and working together with stakeholders.

Read interview

Karin Schölin Bywall
Last modified: 2022-02-01